Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind
Join the ISSCR in Boston, USA.
Save the Date: 11-12 December 2025
Program Description: Developing Pluripotent Stem Cell (PSC)-derived cell therapies presents exciting opportunities for novel and potentially curative approaches to intractable diseases, but also unique challenges that accompany a complex biological drug product. By working from the patient backwards, we can mitigate these challenges and optimize cell therapy development when each step is informed by the requirements of the final product. This unique program reverses the traditional “bench-to-bedside” approach by starting with the end goal – a successful and effective cell therapy - in mind when considering the entire development process. Connect with global leaders on the frontlines of developing ESC & iPSC-derived cell therapies as we bring together pioneers leading the most advanced clinical trials and innovators developing the next generation of technologies and platforms that will shape the future of the field.
Program
*Session speakers to be announced soon.
Session Topics
Clinical Trials: Phase II & Beyond
Katharine Spink, PhD, Dark Horse Consulting, USA
Clinical Trials: Early Trials
Takehiko Kaneko, MD, Heartseed, Japan
Patient Perspectives
Luke Rosen, KIF1A.ORG, USA
“I Wish I Would Have”: Lessons Learned in Product Development
Greg Russotti, PhD, Century Therapeutics, USA
Uma Lakshmipathy, PhD, Thermo Fisher Scientific, USA
Now You See Me, Now You Don’t: Ensuring Cell Survival
Dan Kemp, PhD, Shinobi Therapeutics, USA
Next Generation Cell Therapies in the Pipeline
Alexander Ng, PhD, GC Therapeutics, USA
Laura Koivusalo, PhD, StemSight, Finland
Robert Zweigerdt, PhD, Medizinische Hochschule Hannover, Germany
Advances in Cell Therapy Technologies, Platforms, and Manufacturing
Organizers
Claire Henchcliffe, MD, PhD (Co—Chair)
UCI, USA
Stefan Irion, MD
BlueRock Therapeutics, USA
Ana Hidalgo-Simon, MD, PhD
reNEW & LUMC, The Netherlands
Erin Kimbrel, PhD (Co—Chair)
Astellas Pharmaceuticals, USA
Thomas Hassing Ronøe Carlsen, PhD
Cellerator, Denmark
Felicia Pagliuca, PhD
Vertex Pharmaceuticals, USA
Travel & Accommodations
Venue
Hyatt Regency Boston Cambridge
575 Memorial Drive
Cambridge, MA 02139
USA
Sponsor & Exhibit
This ISSCR event provides a fantastic opportunity to raise your company’s visibility and develop connections with the global scientific community advancing the stem cell field! Share your products, tools, and services that can help support and accelerate their research.
Contact exhibits@isscr.org to partner with us at this event!
Logo Toolkit for Sponsors & Exhibitors
Sponsors and exhibitors and welcome to use the below meeting logos to promote their participation in the event. However, attendees, speakers, presenters, sponsors, exhibitors, and partners may not use or edit the corporate, main ISSCR logo in any promotions. If you would like a custom graphic, please contact ISSCR’s Marketing Team at marketing@isscr.org.
This program is made possible by:
Sponsors
Official Meeting Journal
Stem Cell Reports is an open access forum communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on manuscripts that report original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.